Comera Life Sciences Holdings, Inc. (CMRA): Price and Financial Metrics


Comera Life Sciences Holdings, Inc. (CMRA): $1.37

0.05 (+3.79%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CMRA to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

CMRA Stock Price Chart Interactive Chart >

Price chart for CMRA

CMRA Price/Volume Stats

Current price $1.37 52-week high $11.44
Prev. close $1.32 52-week low $1.11
Day low $1.29 Volume 17,000
Day high $1.37 Avg. volume 116,217
50-day MA $1.40 Dividend yield N/A
200-day MA $0.00 Market Cap 27.19M

Comera Life Sciences Holdings, Inc. (CMRA) Company Bio


Comera Life Sciences Holdings, Inc. operates as a pre-clinical biotechnology company. It develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. The company's SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. Its products pipeline include CLS-001, an SQ formulation of a marketed, IV administered monoclonal antibody therapeutic for Crohn's disease and ulcerative colitis; CLS-002, an SQ formulation of a marketed, IV-administered immuno-oncology targeted monoclonal antibody for various oncology indications. The company was founded in 2014 and is based in Woburn, Massachusetts.


CMRA Latest News Stream


Event/Time News Detail
Loading, please wait...

CMRA Latest Social Stream


Loading social stream, please wait...

View Full CMRA Social Stream

Latest CMRA News From Around the Web

Below are the latest news stories about COMERA LIFE SCIENCES HOLDINGS INC that investors may wish to consider to help them evaluate CMRA as an investment opportunity.

Comera Life Sciences to Present at 22nd Annual PepTalk Conference

WOBURN, Mass., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA) (“Company” or “Comera”), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety and convenience, today announced it will present at the 22nd Annual PepTalk Conference, in San Diego on Wednesday, Jan. 18, 2023 at 5:15 p.m. PT. The conference will run from Monday, Jan. 16 through Friday, Jan. 20. Subhashchandra Naik, Ph.D., Senior R

Yahoo | January 12, 2023

Comera Life Sciences Holdings Inc. (NASDAQ: CMRA) Is Up 24.09% – Can It Revive?

Comera Life Sciences Holdings Inc. (NASDAQ:CMRA) price is hovering higher on Monday, January 09, jumping 24.09% above its previous close. A look at today’s price movement shows that the recent level at last check reads $1.51, with intraday deals fluctuating between $1.17 and $1.58. Taking into account the 52-week price action we note that the … Comera Life Sciences Holdings Inc. (NASDAQ: CMRA) Is Up 24.09% – Can It Revive? Read More »

Stocks Register | January 9, 2023

Comera Life Sciences to Present at Upcoming Biotech Showcase Investor Conference

WOBURN, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient delivery, access, safety and convenience, today announced that the company will present at the upcoming Biotech Showcase Conference on Tuesday, January 10, 2023 at 9:00 AM PT in San Francisco, CA. The Company will also host one-on-one meetings with investors from Monday, January 9 through W

Yahoo | January 5, 2023

Comera Life Sciences Closes $3.6 Million Private Placement Priced At-the-Market under Nasdaq Rules

WOBURN, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today announced that it has completed a private placement to existing stockholders, of 2,406,242 units, at a purchase price of $1.48 per unit, with each unit consisting of one share of the Company’s common stock and one five-year warrant to purchase two shar

Yahoo | January 4, 2023

Comera Life Sciences to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference

WOBURN, Mass., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. ( Nasdaq: CMRA ), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today announced it will be participating in the Benchmark Company’s 11 th Annual Discovery One-on-One Investor Conference to be held Thursday, December 1, 2022 at the New York Athletic Club in New York.

GlobeNewswire | November 17, 2022

Read More 'CMRA' Stories Here

CMRA Price Returns

1-mo -9.57%
3-mo 13.22%
6-mo -50.90%
1-year N/A
3-year N/A
5-year N/A
YTD 11.38%
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6314 seconds.